Association between lipoprotein(a) and insulin-like growth factor I during puberty and the relationship to microalbuminuria in children and adolescents with IDDM

Diabetes Care

Volumn 18, Issue 7, 1995, Pages 933-939

  Rudberg, Susanne ^a   Persson, Bengt ^a  

^a ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; ENALAPRIL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METOPROLOL; SOMATOMEDIN C; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; FEMALE; HORMONE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PUBERTY; REGRESSION ANALYSIS; SUBCUTANEOUS DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE;

EID: 0029014053     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.18.7.933     Document Type: Article

References (46)

1. Rhoads GG, Dahlen GH, Berg K, Morton NE, Dannenberg AL: Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 256:2540-2544, 1986
2. Borch-Johnsen K, Kreiner S: Proteinuria: value as a predictor of cardiovascular mortality in insulin-dependent diabetes mellitus. Br Med J 294:1651-1654, 1987
3. Jensen T, Borch-Johnsen K, Kofoed-Enevoldsen A, Deckert T: Coronary heart disease in young type-1 (insulin-dependent) diabetic patients with and without diabetic nephropathy: incidence and risk factors. Diabetologia 30:144-148, 1987
4. Jensen T, Stender S, Deckert T: Abnormalities in plasma concentrations of lipoproteins and fibrinogen in type-1 (insulin-dependent) diabetic patients with increased urinary albumin excretion rate. Diabetolgia 31:142-145, 1988
5. Jones SL, Close CF, Mattock MB, Jarrett RJ, Keen H, Viberti GC: Plasma lipid and coagulation factor concentrations in insulin dependent diabetics with microalbuminuria. Br Med J 298:487-490, 1989
6. Guillauseau PJ, Peynet J, Chanson P, Legrand A, Altman JJ, Poupon J, N'guyen M, Rosselet F, Lubetzki J: Lipoprotein(a) in diabetic patients with and without chronic renal failure. Diabetes Care 15: 976-979, 1992
7. Kapelrud H, Bangstad H-J, Dahl-Jörgensen K, Berg K, Hansen KF: Serum Lp(a) lipoprotein concentrations in insulin-dependent diabetic patients with microalbuminuria. Br Med J 303:675-678, 1991
8. Jenkins AJ, Steele JS, Janus ED, Best JD: Increased plasma apolipoprotein(a) levels in IDDM patients with microalbuminuria. Diabetes 40:787-790, 1991
9. Maser RE, Usher D, Becker DJ, Drash AL, Kuller LH, Orchard TJ: Lipoprotein(a) concentration shows little relationship to IDDM complications in the Pittsburgh Epidemiology of Diabetes Complications Study cohort. Diabetes Care 16:755-758, 1993
10. Dahlquist G, Rudberg S: The prevalence of microalbuminuria in diabetic children and adolescents and its relation to puberty. Acta Paediatr Scand 76:795-800, 1987
11. Rudberg S, Ullman E, Dahlquist G: Relationship between early metabolic control and the development of microalbuminuria: a longitudinal study in children and adolescents with type 1 (insulin-dependent) diabetes. Diabetologia 36:1309-1314, 1993
12. Mercado M, Molitch ME, Baumann G: Low plasma growth hormone binding protein in IDDM. Diabetes 41:605-609, 1992
13. Couper JJ, Bates DJ, Cocciolone R, Magarey AM, Boulton TJC, Penfold JL, Ryall RG: Association of lipoprotein(a) with puberty in IDDM. Diabetes Care 16:869-873, 1993
14. Olivecrona H, Ericsson S, Berglund L, Angelin B: Increased concentrations of serum lipoprotein(a) in response to growth hormone treatment. Br Med J 306:1726-1727, 1993
15. Zenobi PD, Holzman P, Glatz Y, Reisen WF, Froesch ER: Improvement of lipid profile in type-2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor 1. Diabetologia 36:465-469, 1993
16. Friedewald WT, Levy RI, Fredrickson DS: Estimate of the concentration of lowdensity-lipoprotein cholesterol in plasma, without use of preparative ultracentrifuge. Clin Chem 18:499-502, 1972
17. Bang P, Eriksson U, Sara V, Wivall I-L, Hall K: Comparisons of acid ethanol extraction and gel filtration before IGF-I and IGF-II radioimmunoassays: improvement of determinants in acid ethanol extracts by use of truncated IGF-1 as radioligand. Acta Endocrinol 124:620-629, 1991
18. Teppo AM: Immunoturbidimetry of albumin and immunoglobulin in the urine. Clin Chem 28:1359-1361, 1982
19. 51Cr EDTA in children. Acta Paediatr Scand 73:379-382, 1984
20. Kofoed-Enevoldsen A, Borch-Johnsen K, Kreiner S, Nerup J, Deckert T: Declining incidence of persistent proteinuria in type-1 (insulin-dependent) diabetic patients in Denmark. Diabetes 36:205-209, 1987
21. Kostraba Jn, Dormab JS, Orchard TJ, Becker DJ, Ohki Y, Ellis D, Doft BH, Lobes LA, LaPorte RE, Drash A: Contribution of diabetes duration before puberty to development of microvascular complications in IDDM subjects. Diabetes Care 12:686-693, 1989
22. Mortensen HB, Marinelli K, Norgaard K, Min K, Kastrup KW, Ibsen KK, Villumsen J, Parving H-H, Danish Study Group of Diabetes in Childhood: A nationwide cross-sectional study of urinary albumin excretion rate, arterial blood pressure and blood glucose control in Danish children with type-1 diabetes mellitus. Diabetic Med 7:887-897, 1990
23. Lundbaek K, Christensen NJ, Jensen VA, Johansen K, Steen Olsen T, Prange Hansen A, Orskov H, Osterby R: Diabetes, diabetic angiopathy and growth hormone. Lancet ii:131-133, 1970
24. Yip J, Mattock MB, Morocutti A, Sethi M, Trevisan R, Viuberti GC: Insulin resistance in insulin-dependent diabetic patients with microalbuminuria. Lancet 342:883-887, 1993
25. Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP: Increased overnight growth hormone concentrations in diabetes compared with normal adolescents. J Endocrinol Metab 71:1356-1362, 1990
26. Batch JA, Baxter RC, Werther G: Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes. J Clin Endocrinol Metab 73:964-968, 1991
27. Flyvberg A: The role of insulin-like growth factors (IGFs) and IGF binding proteins (Abstract). In Proc of the 15th IDF Congress. Kobe, November 6-11, 1994, Novo Nordisk Pharma Ltd. 1994, p. 26
28. Dills DG, Moss SE, Klein R, Klein BEK, Dais M: Is insulin-like growth factor 1 associated with diabetic retinopathy? Diabetes 39:191-195, 1990
29. Merimee TJ, Zapf J, Froesch ER: Studies in diabetics with and without retinopathy. N Engl J Med 309:527-530, 1983
30. Ashton IK, Pockock AE, Turner RC, Bron AJ: Plasma somatomedin activity and diabetic retinopathy. Clin Endocrinol 19: 105-110, 1983
31. Salardi S, Cacciari E, Ballaardini D, Righetti F, Capelli M, Cicognani A, Zucchini S, Natali G, Tassinari D: Relationships between growth factors (somatomedin-C and growth hormone) and body development, metabolic control, and retinal changes in children and adolescents with IDDM. Diabetes 35:832-836, 1986
32. Joven J, Vilella E: Serum levels of lipoprotein (a) in patients with well-controlled non-insulin-dependent diabetes mellitus (Letter). JAMA 265:1113-1114, 1991
33. Duell PB, Hagemenas F, Connor WE: The relationship between serum Lp(a) and insulinemia in healthy nondiabetic adult men. Diabetes Care 17:1135-1140, 1994
34. Henriksson P, Angelin B, Berglund L: Hormonal regulation of serum Lp(a) levels: opposite effects after oestrogen treatment and orchidectomy in males with prostatic carcinoma. J Clin Invest 89: 1166-1171, 1992
35. Soma M, Fumagalli R, Paoletti R, Meschia M, Maini C, Crosignani K, Ghanem J, Gaubatz J, Morrisett JD: Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women (Letter). Lancet 337:612, 1991
36. Uterman G, Mentzel HJ, Kraft HG, Kemmler MG, Seitz C: Lp(a) glycoprotein phenotypes inheritance and relations to Lp(a) concentrations in plasma. J Clin Invest 8:36-42, 1987
37. Uterman G: The mysteries of Lp(a) lipoprotein. Science 246:904-910, 1990
38. Klausen IC, Berg Schmidt E, Lervang HH, Gerdes LU, Ditzel J, Faergeman O: Normal lipoprotein (a) concentrations and apolipoprotein (a) isoforms in patients with insulin-dependent diabetes mellitus. Eur J Clin Invest 22:538-541, 1992
39. Loscaizo J, Weinfeld M, Fless GM, Scanu AM. Lipoprotein(a), fibrin binding and plasminogen activation. Arteriosclerosis 10:240-245, 1990
40. Rath M, Niendorf A, Reblin T, Dietel M, Krebber HJ, Beisegel U: Detection and quantification of lipoprotein (a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 9:579-592, 1989
41. Dahlen G, Ericson C, Berg K: In vitro studies of the interaction of isolated Lp(a) lipoprotein and the other serum lipoproteins with glycosaminoglycans. Clin Genet 34:36-42, 1978
42. Haffner SM, Gruber K, Aldrete G, Tuttle KTR: Increased Lp(a) concentrations in renal failure. J Am Soc Nephrol 3:1156-1162, 1992
43. Wanner C, Rader D, Bartens W, Kramer J, Brewer HB, Schollmeyer P, Wieland H: Elevated plasma lipoprotein (a) in patients with the nephrotic syndrome. Ann Intern Med 119:263-269, 1993
44. Appel G, Blum B, Chien S, Kunis C, Appel A: The hyperlipidemia of the nephrotic syndrome: relation to plasma albumin concentration, oncotic pressure and viscosity. N Engl J Med 312:1544-1548, 1985
45. Keilani T, Schlueter WA, Levin ML, Battle DC: Improvement of lipid abnormalities associated with proteinuria using fosinopril, an angiotensin-converting enzyme inhibitor. Ann Intern Med 118:246-254, 1993
46. Rouffy J, Jaillard J: Effects of two antihypertensive agents on lipids, lipoproteins and apoproteins A and B: comparison of prazosin and atenolol. Am J Med 80:100-103, 1986